A simple disease- guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study. J Am Coll Cardiol. 2016;68:881 91. S2.2-22. Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133:849 58. S2.2-23. Patel J, Al Rifai M, Blaha MJ, et al. Coronary artery calcium improves risk assessment in adults with a family history of premature coronary CLINICAL STATEMENTS AND GUIDELINES heart disease: results from the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8:e003186. S2.2-24. Pursnani A, Massaro JM, D Agostino RB Sr, et al. Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA. 2015;314:134 41. S2.2-25. Valenti V, Hartaigh B, Heo R, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a pro- spective follow-up of 9 715 individuals. JACC Cardiovasc Imaging. 2015;8:900 9. S2.2-26. Yano Y, O Donnell CJ, Kuller L, et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol. 2017;2:986 94. S2.2-27. Yeboah J, Young R, McClelland RL, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67:139 47. S2.2-28. Multi-Ethnic Study of Atherosclerosis. MESA 10-Year CHD Risk with Coronary Artery Calcification. Available at: https://www.mesa- nhlbi.org/MESACHDRisk/MesaRiskScore/RiskScore.aspx. Accessed September 21, 2018. S2.2-29. Astronaut Cardiovascular Health and Risk Modification (Astro- CHARM). 10-Year ASCVD Risk Calculator with Coronary Artery Calcium. Available at: http://astrocharm.org/calculator-working. Accessed September 21, 2018. S2.2-30. Gupta A, Lau E, Varshney R, et al. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2017;10: 833 42. S2.2-31. 